Vigamox eye drops are an antibacterial drug that has wide range actions (fluoroquinolones) for topical use in ophthalmology. It has a bactericidal effect against many types of bacteria, including streptococci, staphylococci, Escherichia coli, salmonella, diphtheria, chlamydia pathogens, as well as strains of microorganisms that are resistant to the action of other groups of antibacterial drugs.

Composition and form of release

The drug is available in the form of transparent yellow-green drops.

1 ml of the medicine contains:

• the main active substance: 5.45 mg moxifloxacin (5 mg moxifloxacin)
• Excipients: boric acid, sodium chloride, sodium hydroxide, purified water.

Available in vials of 3 and 5 ml, which are packed in plastic dropper bottles.

pharmachologic effect

Vigamox has an effect on the following groups of pathogens:

• gram-positive (Staphylococcus aureus, Streptococcus pyogenes, Streptococcus pneumoniae);
• gram-negative (Haemophilus parainfluenzae, Haemophilus influenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Enterobacter cloacae, Escherichia coli);
• atypical (Chlamydia pneumoniae, Mycoplasma pneumoniae).

Microorganisms (Streptococcus milleri, Str. Agalactiae, Streptococcus mitior, Streptococcus dysgalactiae, Staphylococcus epidermidis, Staphylococcus saprophyticus, St. cohnii, Staphylococcus hominis, St. haemolyticaki Protein, Enterobacter vulmedius Morganella morganii, Providencia stuartii, Providencia rettgeri, Klebsiella oxytoca, Enterobacter aerogenes, Bordetella pertussis, Enterobacter agglomerans, Enterobacter Intermedius, Proteus mirabilis, Proteus vulgaris, Enterobacter Sakazaki, Providencia oxytoca, Providencia oxytoca, Providenciaella morganides , Bacteroides eggerthii, Bacteroides thetaiotaornicron, Bacteroides uniformis, Porphyromonas spp., Porphyromonas anaerobius, Fusobacterium spp., Porphyromonas asaccharolyticus, Porphyromonas magnus, Propionibacterium rapplingens, Clostridium perfringens., Clostridium perfring. p, Caxiella burnettii, Legionella pneumophila) showed sensitivity in in vitro studies, however, the effectiveness and safety of treatment of these infections has not been confirmed.

The effectiveness of Vigamox moxifloxacin will directly depend on the content in the blood and tissues. The bactericidal concentration in small amounts is practically the same with the minimum inhibitory concentration. Resistance develops by mechanisms that inactivate cephalosporins, macrolides, penicillins, aminoglysosides, tetracyclines, do not affect the antibacterial properties of moxifloxacin. There is no cross-resistance between moxifloxacin and the listed drugs.

The plasmid-mediated direction of the development of Vigamox resistance was also not observed. There is a low incidence of resistance to moxifloxacin. Studies have shown that the development of drug resistance is slow, due to the successive passage of mutations.

Moesifloxacin in the composition of the drug, with repeated exposure to microorganisms in subminimal inhibitory concentrations, slightly increases the indicators. Fluoroquinolone preparations interact with each other to show cross-resistance. However, there are also gram-positive and anaerobic microorganisms that are resistant to other fluoroquinolones and sensitive to moxifloxacin. After ingestion, it penetrates in large quantities into the systemic circulation, it can also penetrate into breast milk.

Indications for the use of Vigamox

Eye drops are effective:

• in the treatment of inflammatory diseases of the anterior parts of the eye, which cause microorganisms sensitive to moxifloxacin, including keratitis, conjunctivitis, barley, blepharitis, corneal ulcers, dacryocystitis;
• for prophylactic purposes and treatment of eye inflammation caused by bacteria as a result of trauma and eye surgery.

Contraindications

Drops ophthalmic Vigamox should not be taken in case of hypersensitivity to the main active ingredient and excipients of the drug.

Side effects

Locally side effects after taking Vigamox may be as follows: itching, discomfort, dry eyes, keratitis, subconjunctival bleeding, vision as in a fog. It is extremely rare that such side effects: pharyngitis, headache, loss of consciousness, respiratory failure, Quincke's edema. If any side effects occur, the drug should be stopped immediately.

Instructions for use

Eye drops provide fast and long lasting healing effect... The medicine will begin to act within 10-15 minutes after administration, the duration of the action is about 6-8 hours.

Method and dosage

Eye drops are instilled into the sore eye 1 drop 3 times a day.

As a rule, improvement should occur within 5 days after taking Vigamox, but therapy should be continued for another 2 days.

If after 5 days there is no improvement, you need to see a doctor. Perhaps the diagnosis was wrong and a new treatment needs to be found. The duration of the course will depend on the severity of the disease.

When the cap from the Vigamox vial is removed, do not touch the tip of the pipette in order to exclude the possibility of contamination of the solution with microbes. Treatment with drops of newborns and children is also highly effective, therefore the use of the drug is in the same dosage as for adults.

The instruction for use notes that Vigamox eye drops can be taken in the treatment of children and the elderly without dosage adjustment. When treating infections of the anterior parts of the eye, do not use soft contact lenses. If, after the drug has been used, the clarity of vision is impaired, you need to refrain from work for a while, which requires increased concentration of attention, as well as driving a vehicle. Once opened, the eye drops bottle cannot be stored for more than 4 weeks.

Vigamox for children

Eye drops can be prescribed for children over 1 year of age. The doses will be similar to those for an adult.

During pregnancy and lactation

There is no confirmed data on the use of the drug during gestation and breastfeeding. For this reason, Vigamox drops are prescribed to a pregnant woman only when the expected benefit for the mother exceeds possible risks for a child. The drug passes into breast milk, therefore, during treatment with Vigamox breast-feeding will have to be stopped for the entire period of therapy. During studies that were carried out on animals, it was found that moxifloxacin at a dose of 500 mg per kilogram of body weight per day does not have a teratogenic effect. This dose is approximately 21.7 thousand times more than the recommended daily dose for a person. Studies have shown that there was a decrease in fetal body weight, as well as a delay in skeletal and muscle development. At a dose of 100 mg per 1 kg of body weight per day, the incidence of decreased growth in the newborn animal increased.

Overdose

An overdose of Vigamox minimizes the limited space of the conjunetic sac. If the agent was applied orally in a random way, then it will not cause intoxication of the body. If an excessive amount of the drug gets into the eyes, rinse immediately with plenty of warm water.

special instructions

The instructions for use indicate that the treatment is carried out until the symptoms of the disease completely disappear. The duration of the course of treatment can only be prescribed by the attending physician. It should be remembered that self-medication and overdose will never be beneficial. If Vigamox is taken for a long time, just like when taking any other antibacterial drug, microorganisms that are resistant to the action of the drug may multiply excessively. If the infection develops rapidly, you should immediately consult a doctor for the selection of other medicines.

Interaction with other drugs

There are no confirmed studies of the interaction of moxiflocacin when taken with others drugs... Clinically significant drug interactions of the Vigamox substance with warfarin, oral contraceptives, digoxin, ranitidine, probenicide, glibenclamide are not observed.

Studies have shown that the substance does not inhibit the isoenzymes CYP2D6, CYP3A4, CYP2C9 or CYP1A2, therefore, we can say that the substance does not change the pharmacokinetic properties of drugs that are metabolized by cytochrome P450 isoenzymes.

Domestic and foreign analogues

Analogs eye drops are the following drugs: Maxicin, Avelox, Moxifloxacin, Moxin, Signicef, Moflox, Moxifor, Moxifur, Floxal, Tevalox, Betacyprol, Vitabact, Decamethoxin, Ophthalmol, Lofox, Okacin, Oftadec, Normax, Okomistin, Tsftoliphligon, Uuvixni.

Despite the fact that Vigamox has a lot of analogues, only an ophthalmologist can replace the drug, because each medicinal product includes both the main active substances and auxiliary ones, and the reaction of the body can be the most unpredictable.

Price in pharmacies

The price of Vigamox eye drops in different pharmacies can vary significantly. This is due to the use of cheaper components and the pricing policy of the pharmacy chain.

Read the official information about Vigamox eye drops, the instructions for use of which include general information and a treatment regimen. The text is provided for informational purposes only and cannot serve as a substitute for a doctor's consultation.

Vigamox - antibacterial drug, for topical application in the eyes, with a wide spectrum of action. It has a bactericidal effect. The composition contains - moxifloxacin (fluoroquinolone).

Acts on gram-positive, gram-negative, anaerobes, atypical, acid-fast bacteria. The drug is effective against bacteria resistant to B-lactam antibiotics, macrolides. The drug goes deep into the tissue of the eye, creating in it high concentration medicines.

Ingredients: moxifloxacin hydrochloride, boric acid, purified water, hydrochloric acid and / or sodium hydroxide, sodium chloride. Produced in polyethylene dropper bottles with a volume of 3 ml, 5 ml.

pharmachologic effect

Vigamox inhibits bacterial enzymes topoisomerase IV, II, which are necessary for transcription, replication and recombinant bacterial DNA. Methoxyl group C8 inhibits resistant strains of gram-positive bacteria. The C7 group destroys quiniline receptors in bacteria. Moxifloxocin resistance is rare.

Pharmacokinetics: when the agent is applied topically, it enters the bloodstream (resorptive effect). The maximum concentration is 2.7 ng / ml, the half-life is 13 hours.

Indications for use

Eye infections (conjunctivitis, meibomyitis, keratitis, eye ulcers,), including purulent ones, caused by the following microorganisms:

• Streptococcus pneumoniae.
• Streptococcus viridans.
• Acinetobacter sp.
• Klebsiella pneumoniae.
• Corynebacterium spp.
• Haemophilus "alconae".
• Pseudomonas aeruginosa.
• Moraxella catarrhalis.
• Streptococcus mitis.
• Staphylococcus warneri.
• Staphylococcus haemolyticus.
• Staphylococcus epidermidis.
• Staphylococcus aureus.

Instructions for use

For adults and children from 1 year old, bury 1 drop in the infected eye for 7 days.

Can I give it to children?

Studies were carried out, during which it was found that taking Vigamox in children over 1 year old is effective and safe in the treatment and prevention of bacterial eye diseases.

The drug is not prescribed for infants due to a violation of the formation of articular surfaces, bones. What threatens in the future with a violation of the osteoarticular system.

Nursing mothers at the time of taking Vigamox should stop feeding the baby, due to the possible ingestion of moxifloxocin contained in Vigamox into breast milk.

Pregnant women should not take the drug. Moxifloxocin is transplantable and accumulates in the amniotic fluid, fetal bloodstream. Studies were carried out, during which they found out about the teratogenic effect in animals, which was manifested by a decrease in fetal weight and impaired formation of bones and joints. Doses exceeding therapeutic ones were used.

Side effects

• Redness of the conjunctiva, eyes.
• Pinpoint keratitis.
• Corneal defect.
• Itching of the eyelids, eyes.
• Hemorrhage under the conjunctiva.
• Swelling of the eye, blurred vision.
• Decreased vision.
• Discomfort in the eye.
• Lachrymation.
• Photophobia.

• Dysgeusia (taste disorder).
• Feeling of numbness, tingling sensation (paresthesia).
• Rhinorrhea.
• Hypersensitivity (allergic reactions).
• Decreased hemoglobin.
• Pain in the pharynx, larynx.
• Increased alanine aminotransferase.
• Feeling of palpitations.
• Increased gamma glutamyl transferase.

Contraindications

• Allergy.
• Damage caused by the herpes virus (treelike keratitis).
• Viral eye diseases.
• Fungal diseases (mycoses).
• Lactation.
• Pregnancy.
• Up to a year in children.

Analogs

The effects and composition are similar: Levobax, Heinemox, Levomak, Ciprofarm, Lomadey, Plevilox, Moxin, Floxal

Drug price: 200-300 rubles.

Antimicrobial agent Vigamox has a bactericidal effect from the group of fluoroquinolones. This drug is widely used in the local treatment of conjunctivitis and affects a wide range of microorganisms - gram-negative and gram-positive bacteria, anaerobes, atypical and acid-fast bacteria: Chlamydia spp., Legionella spp., Mycoplasma spp. Vigamox is effective against strains of microorganisms resistant to macrolides and resistant to beta-lactam antibiotics.

Vigamox affects the following groups of pathogens: gram-positive - Staphylococcus aureus (including colonies resistant to methicillin), Streptococcus pyogenes (group A), Streptococcus pneumoniae (including colonies resistant to macrolides and penicillin); gram-negative - Haemophilus influenzae, Moraxella catarrhalis, Haemophilus parainfluenzae, Enterobacter cloacae, Klebsiella pneumoniae, Escherichia coli; atypical - Mycoplasma pneumoniae, Chlamydia pneumoniae. The microorganisms listed below are susceptible to moxifloxacin in in vitro studies, but safety and efficacy in the treatment of these infections has not been proven. These pathogens include gram-positive microorganisms: Streptococcus milleri, Str. agalactiae, Streptococcus mitior, Streptococcus dysgalactiae, Staphylococcus epidermidis (including methicillin-sensitive colonies), Staphylococcus saprophyticus, St. cohnii, Staphylococcus hominis, St. haemolyticus, Enterobacter aerogenes, Enterobacter agglomerans, Enterobacter sakazaki, Proteus mirabilis, Enterobacter Intermedius, Proteus vulgaris, Morganella morganii, Providencia stuartii, Providencia rettgeri. Gram-negative microorganisms: Klebsiella oxytoca, Enterobacter aerogenes, Bordetella pertussis, Enterobacter agglomerans, Enterobacter Intermedius, Proteus mirabilis, Proteus vulgaris, Enterobacter sakazaki, Providencia rettgeri, Morganella morgana, Providencia stuarti. Anaerobic microorganisms: Bacteroides distasonis, Bacteroides fragilis, Bacteroides ovatus, Bacteroides eggerthii, Bacteroides thetaiotaornicron, Bacteroides uniformis, Porphyromonas spp., Porphyromonas anaerobius. ramosum, Prevotella spp. Atypical microorganisms: Caxiella burnettii, Legionella pneumophila.

The effect of moxifloxacin depends on its content in tissues and blood. The minimum bactericidal concentration is practically equal to the minimum inhibitory concentration.
The mechanisms of development of resistance, which inactivate cephalosporins, penicillins, macrolides, tetracyclines, aminoglycosides do not affect the antibacterial effect of moxifloxacin. There is no cross-resistance between these groups of drugs and moxifloxacin. Also, a plasmid-mediated pathway of resistance development was not observed. The incidence of resistance to moxifloxacin is low. In vitro studies have shown that due to a series of successive mutations, drug resistance develops slowly. Repeated exposure of microorganisms to moxifloxacin in subminimal inhibitory concentrations increases the MIC values ​​slightly. Cross-resistance has been noted between the drugs of the fluoroquinolone series, however, some anaerobic and gram-positive microorganisms that are resistant to other fluoroquinolones remain sensitive to moxifloxacin.

Indications for use

Vigamox used in the local treatment of conjunctivitis caused by microorganisms sensitive to moxifloxacin.

Mode of application

Vigamox instilled into the sore eye (or eyes) for 4 days, 1 drop 3 times a day. After removing the cap, do not touch foreign objects with the tip of the pipette, because this can lead to microbial contamination of the solution.
The use of Vagamox drops in children and newborns also has high efficiency and safety, therefore, their use is possible in the same dose as in adults.

Side effects

Local side effects include dry eyes, itching, transient discomfort, blurred vision, subconjunctival bleeding, keratitis.
In rare cases, a systemic effect may appear: respiratory failure, pharyngitis, angioedema, headache, loss of consciousness.

Contraindications

Eye drops Vigamox do not apply in case of hypersensitivity to the main or auxiliary components of the drug.

Pregnancy

Vigamox prescribed for strict indications, if there is no effect of treatment with drugs from other groups.

Interaction with other medicinal products

Local application excludes the possibility of interaction of moxifloxacin with other drugs.

Overdose

Overdose is impossible due to the limited space of the conjunctival sac. Accidental oral administration of the drug also does not cause intoxication.

Release form

Eye drops, bottle of 3 and 5 ml.

Storage conditions

In a closed bottle at a temperature of 20-25 degrees Celsius.

Composition

1 ml of eye drops contains:
The main active ingredient: moxifloxacin hydrochloride 5.45 mg (corresponds to 5 mg of moxifloxacin);
Auxiliary components: boric acid, sodium chloride, sodium hydroxide and / or hydrochloric acid, purified water.

Additionally

With prolonged use Vigamox As with any antibacterial agent, excessive multiplication of drug-resistant microorganisms can occur. If superinfection develops, it is recommended to consider alternative treatments.
If any side effects it is necessary to stop using Vigamox.

main parameters

Name:	VIGAMOX
ATX code:	S01AX22 -

Instructions for medical use medicinal product

VIGAMOX tm

Tradename

Vigamox tm

International non-proprietary name

Moxifloxacin

Dosage form

Eye drops 5ml

Composition

1ml contains

active substance - moxifloxacin hydrochloride 5.45mg (equivalent to 5mg moxifloxacin),

Excipients: sodium chloride, boric acid, hydrochloric acid and / or sodium hydroxide (for pH correction 6.5-7.0), purified water.

Description

Transparent greenish-yellow solution.

Pharmacotherapeutic group

Drugs for the treatment of eye diseases. Antibacterial drugs. Other antibacterial drugs.

ATX code S01AX22

Pharmacological properties

Pharmacokinetics

With topical application of Vigamox tm eye drops, systemic absorption of moxifloxacin is possible. The plasma half-life of moxifloxacin is 13 hours.

Pharmacodynamics

Moxifloxacin is a 4th generation fluoroquinolone compound and acts on a wide range of gram-positive and gram-negative bacteria, atypical microorganisms and anaerobes.

Inhibits DNA gyrase and topoisomerase IV, which are necessary for DNA replication of bacteria, their restoration and recombination.

The C8-methoxyl group of moxifloxacin reduces the selection of resistant strains of gram-positive bacteria, in contrast to the C8-H group found in the older generation fluoroquinolones. The large C-7 substituent group of moxifloxacin disrupts the quinolone receptors of bacteria. The bactericidal concentration of moxifloxacin is often equal to or slightly higher than the inhibitory concentration.

Fluoroquinolones, including moxifloxacin, differ in their action from beta-lactam antibiotics, macrolides, and aminoglycosides, so they can affect bacteria that are resistant to them. Organisms resistant to the above dosage forms may be sensitive to moxifloxacin.

Moxifloxacin is active against most strains of the following microorganisms:

AerobicGram-positive microorganisms:

Varieties Corynebacterium including

Corynebacterium diphteriae

Staphylococcus aureus(methicillin sensitive)

Streptococcus pneumoniae

Streptococcus pyogenes

Group Streptococcus viridans

AerobicGra-negative microorganisms:

Enterobacter cloacae

Haemophilus influenzae

Klebsiella oxytoca

Moraxella catarrhalis

Serratia marcescens

Anaerobic microorganisms:

Proprionibacterium acnes

Other microorganisms:

Chlamydia trachomatis

Indications for use

local treatment of purulent bacterial conjunctivitis caused by microorganisms sensitive to the drug

Method of administration and dosage

Instill 1 drop into the affected eye (s) 3 times a day. Usually, an improvement in the condition is observed within 5 days from the start of treatment, after which it is recommended to continue treatment for the next 2-3 days. If no improvement is observed within 5 days from the start of treatment, it is recommended to reconsider the diagnosis and / or treatment. The duration of treatment depends on the severity of the disorder and on the clinical and bacteriological course of the infection.

Do not touch the tip of the pipette to the eyes or any other surface to avoid contamination of the contents of the vial.

When using Vigamox tm eye drops in children, dosage adjustment is not required.

When using Vigamox TM eye drops in elderly patients, dosage adjustment is not required.

When using Vigamox TM eye drops in patients with renal and hepatic insufficiency, dosage adjustment is not required.

To prevent the absorption of eye drops through the nasal mucosa into the systemic circulation, especially when used in newborns and children, it is recommended to press the nasolacrimal canal for 2 to 3 minutes after the drops are injected.

When using more than one topical ophthalmic agent, a medication interval of at least 5 minutes should be observed.

Side effects

Local

Hoften

Eye pain

Eye irritation

Dry eye

Conjunctival hyperemia

Hyperemia of the eye

Infrequently

Corneal epithelial defect

Punctate keratitis

Corneal staining

Corneal bleeding

Conjunctivitis

Swelling of the eye

Discomfort in the eye

Blurred vision

Decreased visual acuity

Eyelid disorders

Erythema of the century

Hypersensitivity of the eye

Systemic

Often

Taste disturbance

Infrequently

Decreased hemoglobin levels

Headache, parasthesia

Discomfort in the nasal cavity

Pain in the pharyngolaryngeal region

Feeling foreign body in the pharyngeal region

Increased alanine aminotransferase levels

Increased levels of gamma glutamyltransferase

The frequency of occurrence of the following adverse reactions cannot be estimated due to insufficient available data:

Local

Eye allergy

Photophobia, increased tearing

Sensation of a foreign body in the eye

Increased intraocular pressure

Endophthalmitis, blepharitis, eye discharge

Ulcerative keratitis, corneal erosion, corneal abrasion,

Corneal opacity, corneal deposits

Corneal edema, corneal infiltration

Systemic

Cardiopalmus

Dizziness

Nausea

Erythema, rash, pruritus, hypersensitivity

The type and severity of adverse reactions in children, including newborns, are similar to those seen in adults.

Contraindications

Hypersensitivity to moxifloxacin, other quinolones or auxiliary components of the drug

Drug interactions

Studies of the drug interaction of Vigamox tm 5mg / ml eye drops with other drugs have not been conducted. Given the low systemic concentration of moxifloxacin after topical ophthalmic application of a medical product drug interactions unlikely.

special instructions

As with other antibacterial agents, long-term use the drug can cause overgrowth of insensitive organisms, including fungi. In case of superinfection, it is necessary to stop taking the drug and consider alternative therapies.

Contact lenses

In the presence of symptoms of bacterial conjunctivitis, the patient is not recommended to wear contact lenses until complete recovery.

The risk of developing an anaphylactic reaction

In patients using systemic quinolone drugs, severe, in some cases fatal hypersensitivity reactions (anaphylaxis) were observed, sometimes immediately after taking the first dose. Some reactions have collapsed of cardio-vascular system, loss of consciousness, vascular edema (including laryngeal, pharyngeal, or facial edema), airway obstruction, shortness of breath, urticaria, and pruritus. If an allergic reaction develops when using moxifloxacin, you must stop taking the drug. A severe acute hypersensitivity reaction to moxifloxacin or any other component of the drug may require emergency therapy. According to clinical indications, oxygen is used and artificial respiration is performed.

Pregnancy

Since the systemic absorption of moxifloxacin is negligible, it is assumed that it does not have an effect on pregnancy.

The medical product can be used during pregnancy.

Lactation

When using Vigamox tm eye drops in therapeutic doses, it is assumed that the drug does not affect the infant.

The medical product can be used while breastfeeding.

Application in pediatrics

Since there are limited data to confirm the safety and efficacy of Vigamox TM in the treatment of conjunctivitis in newborns, the use of of this drug in newborns, it is not recommended for the treatment of conjunctivitis.

Vigamox tm eye drops should not be used for prophylaxis or empirical treatment conjunctivitis, including neonatal gonococcal blenorrhea due to the prevalence of fluoroquinolone-resistant microorganisms Neisseria gonorrhoeae. Patients with eye infections caused by microorganisms Neisseria gonorrhoeae

Newborns with neonatal blenorrhea should receive appropriate treatment for each case, such as systemic treatment in case of infection caused by Chlamydia trachomatis or Neisseria gonorrhoeae.

Eye drops Vigamok with tm not recommended for treatment Chlamydia trachomatis in patients under 2 years of age since the drug has not been evaluated in this group of patients. Patients over 2 years of age with an eye infection caused by Chlamydia trachomatis must take appropriate systemic treatment.

Features of the effect of the drug on the ability to manage vehicle or potentially dangerous mechanisms

As with other eye drops, after instillation, temporary blurred vision or other visual disturbances may occur, which can negatively affect the ability to drive or other potentially dangerous machinery. In this case, you need to wait a while until vision is restored.

Overdose

Vigamox eye drops is an antibacterial drug that is intended for topical use. It has a wide range of activities. The composition contains an antibiotic that must be used for a variety of inflammatory eye diseases.

Eye drops Vigamox - antibacterial drug

Microorganisms can cause a variety of inflammations and therefore it is necessary to fight them. If necessary, you can also use the drug as prophylactic in the postoperative period.

Eye drops composition

If you are planning to purchase Vigamox eye drops, then it is imperative to study the composition. The main component that is contained in the drops is moxifloxacin. After purchasing the solution, you can also study additional components, which include:

• Sodium chloride.
• Hydrochloric acid.
• Purified water.

Now the manufacturer is selling in dropper bottles. Their volume can be 3 ml and 5 ml.

pharmachologic effect

Instructions for the use of Vigamox eye drops informs that this drug has a wide range of uses. Due to its bactericidal action, the drug allows you to quickly get rid of: streptococci, bacteria, E. coli, salmonella, mycoplasma, as well as spirochetes.

After instillation, the drug will enter blood vessels and can pass into breast milk. This influence is considered insignificant and therefore it is necessary to consult with specialists about feeding the child at the time of taking the drops. Vigamox eye drops have a long lasting effect. You can notice the first effect of the drug within 15 minutes. The manufacturer assures that the duration of the effect is 6-8 hours.

Indications and contraindications

If you plan to use this drug, then remember that you need to use it for:

1. Treatments inflammatory processes that arise in the anterior part of the eye. Such diseases include conjunctivitis, blepharitis, and corneal ulcers.
2. Prevention of bacterial inflammation. Similar problems can arise after injuries, as well as transferred operations.

During use, you can also push with contraindications. The main problem that you may encounter while taking is an individual intolerance to moxifloxacin, which is contained in the composition.

Vigamox eye drops instruction

If you plan to use these drops, then it is imperative to study the instructions. It indicates that the drug must be used 1 drop three times a day. The treatment process will depend on the symptoms that caused the disease. Stop taking it only if you completely get rid of the problem.

Side effects

You may also experience a variety of symptoms while using this drug. allergic reactions... Sometimes, after instilling drops, you may feel a burning sensation, a slight tingling sensation, photophobia, and tearing. In rare cases, you may experience headaches or minor redness.

special instructions

After making these drops, various clinical researches, but studies on the effect of the drug during pregnancy have not been conducted. That is why it is not recommended to use the drug for pregnant women. If necessary, these drops can also be used for the elderly and children.

When using drops, apply mild contact lenses is prohibited. If after application you observe that your vision has lost its clarity, then it is not recommended to get behind the wheel. If you open the bottle, then remember that it can only be stored for 4 weeks.

Analogs of Vigamox eye drops

The following medicines also have a similar effect today:

1. Moximak.
2. Avelox.
3. Plevilox.

These are the main drugs that have a similar composition. We hope that the information that we have provided about Vigamox eye drops will be useful.